Bank of New York Mellon’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-123,329
| Closed | -$569K | – | 4344 |
|
|
2019
Q1 | $569K | Buy |
123,329
+4,895
| +4% | +$23.2K | ﹤0.01% | 3487 |
|
|
2018
Q4 | $414K | Buy |
118,434
+9,689
| +9% | +$67.3K | ﹤0.01% | 3580 |
|
|
2018
Q3 | $1.1M | Hold |
108,745
| – | – | ﹤0.01% | 3218 |
|
|
2018
Q2 | $787K | Buy |
108,745
+835
| +0.8% | +$5.82K | ﹤0.01% | 3383 |
|
|
2018
Q1 | $653K | Sell |
107,910
-483
| -0.4% | -$3.99K | ﹤0.01% | 3445 |
|
|
2017
Q4 | $1.04M | Sell |
108,393
-49,628
| -31% | -$325K | ﹤0.01% | 3223 |
|
|
2017
Q3 | $1.4M | Buy |
158,021
+1,550
| +1% | +$16K | ﹤0.01% | 3025 |
|
|
2017
Q2 | $1.98M | Buy |
156,471
+1,876
| +1% | +$22.2K | ﹤0.01% | 2858 |
|
|
2017
Q1 | $1.63M | Sell |
154,595
-321,450
| -68% | -$3.43M | ﹤0.01% | 2980 |
|
|
2016
Q4 | $4.38M | Sell |
476,045
-80,265
| -14% | -$907K | ﹤0.01% | 2387 |
|
|
2016
Q3 | $6.56M | Buy |
556,310
+50,151
| +10% | +$762K | ﹤0.01% | 2100 |
|
|
2016
Q2 | $6.55M | Buy |
506,159
+20,446
| +4% | +$298K | ﹤0.01% | 2072 |
|
|
2016
Q1 | $7.77M | Buy |
485,713
+338,392
| +230% | +$6.43M | ﹤0.01% | 1966 |
|
|
2015
Q4 | $4.22M | Buy |
147,321
+18,103
| +14% | +$502K | ﹤0.01% | 2321 |
|
|
2015
Q3 | $3.68M | Sell |
129,218
-17,835
| -12% | -$656K | ﹤0.01% | 2409 |
|
|
2015
Q2 | $5.28M | Buy |
147,053
+17,547
| +14% | +$547K | ﹤0.01% | 2321 |
|
|
2015
Q1 | $3.76M | Buy |
129,506
+2,888
| +2% | +$76.4K | ﹤0.01% | 2463 |
|
|
2014
Q4 | $2.67M | Buy |
126,618
+20,582
| +19% | +$407K | ﹤0.01% | 2664 |
|
|
2014
Q3 | $2.06M | Buy |
106,036
+16,108
| +18% | +$253K | ﹤0.01% | 2861 |
|
|
2014
Q2 | $1.41M | Buy |
89,928
+5,482
| +6% | +$88.6K | ﹤0.01% | 3120 |
|
|
2014
Q1 | $1.75M | Buy |
84,446
+224
| +0.3% | +$4.44K | ﹤0.01% | 2957 |
|
|
2013
Q4 | $1.09M | Sell |
84,222
-39,219
| -32% | -$544K | ﹤0.01% | 3257 |
|
|
2013
Q3 | $1.44M | Buy |
123,441
+80,721
| +189% | +$663K | ﹤0.01% | 3043 |
|
|
2013
Q2 | $197K | Buy |
+42,720
| New | +$157K | ﹤0.01% | 3778 |
|
Other funds holding INSY
WS
Bank of New York Mellon's INSY Position: Q2 2019 in Review
Bank of New York Mellon sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 123,329 shares — an estimated $569K sold.
Bank of New York Mellon first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $7.77M in Q1 2016. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Bank of New York Mellon reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Bank of New York Mellon sold 123,329 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $569K.
- Bank of New York Mellon first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- Bank of New York Mellon's Insys Therapeutics, Inc. position peaked at $7.77M in Q1 2016.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Bank of New York Mellon's 13F filing for Q2 2019, filed 12 Aug 2019.